Natus Completes Acquisition of Neurosurgery Assets from Integra LifeSciences
October 06 2017 - 10:56AM
Natus Medical Incorporated (NASDAQ:BABY) today
announced that it has completed the acquisition of certain
neurosurgery business assets from Integra LifeSciences that was
announced on September 11, 2017. The acquisition includes the
global Camino ICP monitoring product line, including its San Diego
manufacturing facility, and the U.S. rights relating to Integra's
fixed pressure shunts, as well as U.S. rights to Codman's DURAFORM®
dural graft implant, standard EVD catheters and CSF collection
systems.
About Natus Medical
Incorporated
Natus is a leading provider of healthcare
products and services used in the screening, detection, treatment,
monitoring and tracking of common medical ailments in newborn care,
hearing impairment, neurological dysfunction, neurosurgery,
epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can
be found at www.natus.com.
COMPANY CONTACT:Natus Medical
IncorporatedJonathan A. KennedyExecutive Vice President Finance and
Chief Financial Officer(925)
223-6700InvestorRelations@Natus.com
PishPosh (NASDAQ:BABY)
Historical Stock Chart
From Feb 2024 to Mar 2024
PishPosh (NASDAQ:BABY)
Historical Stock Chart
From Mar 2023 to Mar 2024